Jan 30, 2017 12:10 PM

Australia Launches New Cannabis Study for Treating Pancreatic Cancer

Australia is becoming one of the most promising centers of cannabis research. The University of Sidney in cooperation with Chris O’Brein Lifehouse recently started the world’s first clinical trial of treating cancer with cannabis. The trial is set to test the herb’s effects on vomiting and nausea caused by chemotherapy in eighty patients. Now, another group of researchers from Perth will study whether or not cannabis can help treat pancreatic cancer.

Pancreatic cancer is one of the most aggressive forms of cancer and is very difficult to treat. The disease is likely to replace the colorectal form of cancer as the second most common cancer death in just a couple of years. About eight percent of patients diagnosed with pancreatic cancer live longer than five years.

According to Perth News, the researchers from Curtin University are going to treat pancreatic cells cultured outside of the human body with a special combination of cannabis extracts. Scientists hope that the results of the new test will be similar to those of the recent studies on the influence of cannabis on breast cancer. Earlier research showed that THC, a major psychoactive compound found in cannabis, could reduce breast cancer tumors in laboratory rodents. Moreover, cannabis demonstrated the same efficiency as a chemotherapy drug Lapatinib.

The Curtin University research will include tests of the effects of cannabis alone and in combination with chemotherapy drugs. The University is currently working with Zelda Therapeutics, a big biopharmaceutical company from Perth. Both Zelda Therapeutics and Curtin University find the new research to be very promising and hope that it will open alternative therapies for treating pancreatic cancer.

Pre-clinical results of marijuana’s anti-cancer potential are amazing. Studies show that cannabis-based treatments may also have a positive impact on other pancreatic ailments.

Similar news
Australian Philanthropist Donates $3M to Jefferson University
Barry Lambert, an Australian banking magnate and philanthropist, donated $3 million to Thomas Jefferson University's Center for Medical Cannabis Education and Research (CMCER).
Dec 16, 2016 12:15 PM
Australia Uses Tilray Products for New Chemotherapy Trial
Australian researchers are now recruiting cancer patients to study how medical marijuana can prevent vomiting and nausea caused by chemotherapy.
Dec 8, 2016 12:15 PM
University of Canberra Will Trial Medical Marijuana in Treatment of Melanoma
Australian scientists are going to work out a new cannabis-based medicine for skin cancer, with clinical trials to begin in the ACT in 2017.
Jul 22, 2016 9:25 AM